Dh. Kang et al., Post-cyclosporine-mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor, AM J P-REN, 280(4), 2001, pp. F727-F736
Recent studies have demonstrated a role for microvascular and tubulointerst
itial injury in some models of salt- sensitive hypertension. We utilized a
model of post- cyclosporin A (CsA) nephropathy and hypertension to test the
hypothesis that treatment with an angiogenic factor aimed at ameliorating
the microvascular and renal injury would prevent the development of hyperte
nsion. CsA was administered with a low- salt diet for 45 days, resulting in
a renal lesion characterized by afferent arteriolopathy, focal peritubular
capillary loss, and tubulointerstitial fibrosis. Rats were then placed on
a high- salt diet and randomized to receive either vascular endothelial gro
wth factor (VEGF(121))or vehicle for 14 days. Placement of rats with establ
ished CsA nephropathy on a high- salt diet results in the rapid development
of salt- sensitive hypertension. VEGF(121) treatment resulted in lower blo
od pressure, and this persisted on discontinuing the VEGF. VEGF(121) treatm
ent was also associated with a decrease in osteopontin expression, macropha
ge infiltration, and collagen III deposition and markedly stimulated resolu
tion of the arteriolopathy (20.9 +/- 7.8 vs. 36.9 +/- 6.1%, VEGF vs. vehicl
e, P < 0.05). In conclusion, CsA- associated renal microvascular and tubulo
interstitial injury results in the development of salt- sensitive hypertens
ion. Treatment of animals with established CsA nephropathy with VEGF reduce
s the hypertensive response and accelerates histological recovery. The vasc
ular protective effect of VEGF may be due to the improvement of arteriolopa
thy. Angiogenic growth factors may represent a novel strategy for treating
CsA- associated hypertension and renal disease.